skip to main contentskip to main navigation
As of October 1, 2017, the Division of Mental Health and Addiction Services has been transferred to the NJ Department of Health. To access updated information related to the division’s programs and services, please go to http://nj.gov/health/integratedhealth.
skip to main contentskip to main navigation
 
State of New Jersey Deapartment of Human Services title graphic  
 
Division of Mental Health and Addiction Services
New Jersey Helps
NJ Addictions Hotline - 1-844-276-2777
New Jersey Hopeline (1-855-NJ-HOPELINE)
New Jersey Mental Health Cares Hotline
National Suicide Prevention Lifeline 1-800-273-TALK (8255)   Nacional de Prevencion del Suicidio 1-888-628-9454
Veterans Suicide Prevention Lifeline 1-800-273-TALK (8255)
National Center for Posttraumatic Stress Disorder (PTSD)
New Jersey Housing Resource Center
NJ Family Care
Substance Abuse and Mental Health Services Administration (SAMHSA)

Medication for the Treatment of Alcohol Use Disorder (A Pocket Guide provided by SAMHSA & NIH)




The Division of Mental Health and Addiction Services (DMHAS) administers a system of care that consistently offers clients the means to seek and sustain recovery.

The DMHAS promotes evidence-based practices that include Medication-Assisted Treatment Initiative (MATI) in the management of substance use disorders.  The U.S. Department of Human Services, Substance Abuse and Mental Health Services Administration (SAMHSA) defines MATI as the use of medications, in combination with counseling and behavioral therapies, to provide a whole-patient approach to the treatment of substance use disorders.  MATI is clinically driven with a focus on individualized patient care.  Research continues to demonstrate medication, along with behavioral therapies, results in successful outcomes.

The FDA has approved certain medications for the treatment of substance use disorders.  For alcohol use disorder, the medications include:  Naltrexone, Disulfiram and Acamprosate Calcium.  The current medications approved for the treatment of opioid use disorders are:  Methadone, Buprenorphine and Naltrexone.  Click here for more information on these medications.

The DMHAS licenses numerous treatment programs that serve consumers that want more information or are interested in accessing MATI for their treatment.  Licensed treatment programs are listed on this site at http://njsams.rutgers.edu/dastxdirectory/txdirmain.htm.  For information regarding treatment programs call the IME Addictions Access Center at 1-844-276-2777


Back to Specialty Treatment Programs

Research Resources







For information regarding the Medication Assisted Treatment Initiative (MATI), please call (609) 292-6735.

For Information regarding the Vivitrol Enhancement in the DMHAS Networks, please call (609) 292-8186.

For information regarding the Driving Under the Influence Vivitrol Pilot, please call (609) 292-8186.

 
 
 
OPRA - Open Public Records Act NJ Home Logo
Department: DHS Home  |  DHS Services A to Z  |  Consumers & Clients - Individuals and Families  |  Important Resources  |  Divisions & Offices  |  Commissioner & Key Staff  |  Disaster & Emergency Help & Information  |  Press Releases, Public and Legislative Affairs, & Publications  |  Providers & Stakeholders: Contracts, Legal Notices, Licensing, MedComms  |  Get Involved with DHS!
Statewide: NJHome  |  Services A to Z  |  Departments/Agencies  |  FAQs
 
Copyright © State of New Jersey, 1996 - 2014